{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T11:33:56Z","timestamp":1791891236099,"version":"4.3.4"},"reference-count":184,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2008,1,19]],"date-time":"2008-01-19T00:00:00Z","timestamp":1200700800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Drug Discov"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1038\/nrd2780","type":"journal-article","created":{"date-parts":[[2009,1,19]],"date-time":"2009-01-19T17:21:24Z","timestamp":1232385684000},"page":"153-171","source":"Crossref","is-referenced-by-count":418,"title":["Chloride channels as drug targets"],"prefix":"10.1038","volume":"8","author":[{"given":"Alan S.","family":"Verkman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis J. V.","family":"Galietta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,1,19]]},"reference":[{"key":"BFnrd2780_CR1","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.toxicon.2006.07.022","volume":"48","author":"RS Norton","year":"2006","unstructured":"Norton, R. S. & Olivera, B. M. Conotoxins down under. Toxicon 48, 780\u2013798 (2006).","journal-title":"Toxicon"},{"key":"BFnrd2780_CR2","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.toxicon.2006.09.022","volume":"49","author":"WA Catterall","year":"2007","unstructured":"Catterall, W. A. et al. Voltage-gated ion channels and gating modifier toxins. Toxicon 49, 124\u2013141 (2007).","journal-title":"Toxicon"},{"key":"BFnrd2780_CR3","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0969-2126(98)00127-0","volume":"6","author":"RM Wachter","year":"1998","unstructured":"Wachter, R. M., Elsliger, M. A., Kallio, K., Hanson, G. T. & Remington, S. J. Structural basis of spectral shifts in the yellow-emission variants of green fluorescent protein. Structure 6, 1267\u20131277 (1998).","journal-title":"Structure"},{"key":"BFnrd2780_CR4","doi-asserted-by":"crossref","first-page":"6047","DOI":"10.1074\/jbc.275.9.6047","volume":"275","author":"S Jayaraman","year":"2000","unstructured":"Jayaraman, S., Haggie, P., Wachter, R. M., Remington, S. J. & Verkman, A. S. Mechanism and cellular applications of a green fluorescent protein-based halide sensor. J. Biol. Chem. 275, 6047\u20136050 (2000).","journal-title":"J. Biol. Chem."},{"key":"BFnrd2780_CR5","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0014-5793(01)02561-3","volume":"499","author":"LJ Galietta","year":"2001","unstructured":"Galietta, L. J., Haggie, P. M. & Verkman, A. S. Green fluorescent protein-based halide indicators with improved chloride and iodide affinities. FEBS Lett. 499, 220\u2013224 (2001).","journal-title":"FEBS Lett."},{"key":"BFnrd2780_CR6","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1172\/JCI0216112","volume":"110","author":"T Ma","year":"2002","unstructured":"Ma, T. et al. Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera toxin-induced intestinal fluid secretion. J. Clin. Invest. 110, 1651\u20131658 (2002). Identification of the first chloride-channel inhibitor with nanomolar potency and high selectivity. Proof of concept that CFTR inhibitors are useful for diarrhoea treatment.","journal-title":"J. Clin. Invest."},{"key":"BFnrd2780_CR7","doi-asserted-by":"crossref","first-page":"C1734","DOI":"10.1152\/ajpcell.2001.281.5.C1734","volume":"281","author":"LV Galietta","year":"2001","unstructured":"Galietta, L. V., Jayaraman, S. & Verkman, A. S. Cell-based assay for high-throughput quantitative screening of CFTR chloride transport agonists. Am. J. Physiol. 281, C1734\u2013C1742 (2001).","journal-title":"Am. J. Physiol."},{"key":"BFnrd2780_CR8","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1124\/mol.107.043208","volume":"73","author":"R De La Fuente","year":"2008","unstructured":"De La Fuente, R., Namkung, W., Mills, A. & Verkman, A. S. Small-molecule screen identifies inhibitors of a human intestinal calcium-activated chloride channel. Mol. Pharmacol. 73, 758\u2013768 (2008).","journal-title":"Mol. Pharmacol."},{"key":"BFnrd2780_CR9","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1152\/physrev.00029.2001","volume":"82","author":"TJ Jentsch","year":"2002","unstructured":"Jentsch, T. J., Stein, V., Weinreich, F. & Zdebik, A. A. Molecular structure and physiological function of chloride channels. Physiol. Rev. 82, 503\u2013568 (2002).","journal-title":"Physiol. Rev."},{"key":"BFnrd2780_CR10","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.tips.2007.05.004","volume":"28","author":"MD Amaral","year":"2007","unstructured":"Amaral, M. D. & Kunzelmann, K. Molecular targeting of CFTR as a therapeutic approach to cystic fibrosis. Trends Pharmacol. Sci. 28, 334\u2013341 (2007).","journal-title":"Trends Pharmacol. Sci."},{"key":"BFnrd2780_CR11","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1152\/physrev.1999.79.1.S23","volume":"79","author":"D Sheppard","year":"1999","unstructured":"Sheppard, D. & Welsh, M. Structure and function of the CFTR chloride channel. Physiol. Rev. 79, S23\u2013S45 (1999).","journal-title":"Physiol. Rev."},{"key":"BFnrd2780_CR12","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/nature04712","volume":"440","author":"D Gadsby","year":"2006","unstructured":"Gadsby, D., Vergani, P. & Csan\u00e1dy, L. The ABC protein turned chloride channel whose failure causes cystic fibrosis. Nature 440, 477\u2013483 (2006).","journal-title":"Nature"},{"key":"BFnrd2780_CR13","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1126\/science.2772657","volume":"245","author":"JM Rommens","year":"1989","unstructured":"Rommens, J. M. et al. Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 245, 1059\u20131065 (1989).","journal-title":"Science"},{"key":"BFnrd2780_CR14","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1136\/gut.2004.062786","volume":"56","author":"M Wilschanski","year":"2007","unstructured":"Wilschanski, M. & Durie, P. R. Patterns of GI disease in adulthood associated with mutations in the CFTR gene. Gut 56, 1153\u20131163 (2007).","journal-title":"Gut"},{"key":"BFnrd2780_CR15","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.coph.2003.06.012","volume":"3","author":"JR Thiagarajah","year":"2003","unstructured":"Thiagarajah, J. R. & Verkman, A. S. CFTR pharmacology and its role in intestinal fluid secretion. Curr. Opin. Pharmacol. 3, 594\u2013599 (2003).","journal-title":"Curr. Opin. Pharmacol."},{"key":"BFnrd2780_CR16","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000090308","volume":"24","author":"MJ Farthing","year":"2006","unstructured":"Farthing, M. J. Antisecretory drugs for diarrheal disease. Dig. Dis. 24, 47\u201358 (2006).","journal-title":"Dig. Dis."},{"key":"BFnrd2780_CR17","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1111\/j.1523-1755.2004.00967.x","volume":"66","author":"H Li","year":"2004","unstructured":"Li, H., Findlay, I. A., & Sheppard, D. N. The relationship between cell proliferation, Cl\u2212 secretion, and renal cyst growth: a study using CFTR inhibitors. Kidney Int. 66, 1926\u20131938 (2004).","journal-title":"Kidney Int."},{"key":"BFnrd2780_CR18","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/ki.1996.304","volume":"50","author":"CJ Davidow","year":"1996","unstructured":"Davidow, C. J., Maser, R. L., Rome, L. A., Calvet, J. P. & Grantham, J. J. The cystic fibrosis transmembrane conductance regulator mediates transepithelial fluid secretion by human autosomal dominant polycystic kidney disease epithelium in vitro. Kidney Int. 50, 208\u2013218 (1996).","journal-title":"Kidney Int."},{"key":"BFnrd2780_CR19","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1152\/physrev.1999.79.1.S109","volume":"79","author":"BD Schultz","year":"1999","unstructured":"Schultz, B. D., Singh, A. K., Devor, D. C. & Bridges, R. J. Pharmacology of CFTR chloride channel activity. Physiol. Rev. 79, S109\u2013S144 (1999).","journal-title":"Physiol. Rev."},{"key":"BFnrd2780_CR20","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0014-5793(04)00011-0","volume":"558","author":"A Taddei","year":"2004","unstructured":"Taddei, A. et al. Altered channel gating mechanism for CFTR inhibition by a high-affinity thiazolidinone blocker. FEBS Lett. 558, 52\u201356 (2004).","journal-title":"FEBS Lett."},{"key":"BFnrd2780_CR21","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1042\/BJ20080029","volume":"413","author":"E Caci","year":"2008","unstructured":"Caci, E. et al. Evidence for direct CFTR inhibition by CFTRinh-172 based on arginine 347 mutagenesis. Biochem. J. 413, 135\u2013142 (2008).","journal-title":"Biochem. J."},{"key":"BFnrd2780_CR22","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/jps.20228","volume":"94","author":"ND Sonawane","year":"2005","unstructured":"Sonawane, N. D., Muanprasat, C., Nagatani, R. Jr, Song, Y. & Verkman, A. S. In vivo pharmacology and antidiarrheal efficacy of a thiazolidinone CFTR inhibitor in rodents. J. Pharm. Sci. 94, 134\u2013143 (2005).","journal-title":"J. Pharm. Sci."},{"key":"BFnrd2780_CR23","doi-asserted-by":"crossref","first-page":"8187","DOI":"10.1016\/j.bmc.2008.07.044","volume":"16","author":"N Sonawane","year":"2008","unstructured":"Sonawane, N. & Verkman, A. S. Thiazolidinone CFTR inhibitors with improved water solubility identified by structure-activity analysis. Bioorg. Med. Chem. 16, 8187\u20138195 (2008).","journal-title":"Bioorg. Med. Chem."},{"key":"BFnrd2780_CR24","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1085\/jgp.200409059","volume":"124","author":"C Muanprasat","year":"2004","unstructured":"Muanprasat, C. et al. Discovery of glycine hydrazide pore-occluding CFTR inhibitors: mechanism, structure-activity analysis, and in vivo efficacy. J. Gen. Physiol. 124, 125\u2013137 (2004).","journal-title":"J. Gen. Physiol."},{"key":"BFnrd2780_CR25","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1096\/fj.05-4818fje","volume":"20","author":"ND Sonawane","year":"2006","unstructured":"Sonawane, N. D., Hu, J., Muanprasat, C. & Verkman, A. S. Luminally-active, nonabsorbable CFTR inhibitors as potential therapy to reduce intestinal fluid losses in cholera. FASEB J. 20, 130\u2013132 (2006).","journal-title":"FASEB J."},{"key":"BFnrd2780_CR26","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1053\/j.gastro.2007.02.018","volume":"132","author":"N Sonawane","year":"2007","unstructured":"Sonawane, N., Zhao, D., Zegarra-Mora, O., Galietta, L. J. V. & Verkman, A. S. Lectin conjugates as potent, nonabsorbable CFTR inhibitors for reducing intestinal fluid secretion in cholera. Gastroenterology 132, 1234\u20131244 (2007).","journal-title":"Gastroenterology"},{"key":"BFnrd2780_CR27","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.chembiol.2008.05.015","volume":"15","author":"N Sonawane","year":"2008","unstructured":"Sonawane, N., Zhao, D., Zegarra-Mora, O., Galietta, L. J. V. & Verkman, A. S. Nanomolar CFTR inhibition by pore-occluding divalent polyethylene glycol-malonic acid hydrazides. Chem. Biol. 15, 718\u2013728 (2008).","journal-title":"Chem. Biol."},{"key":"BFnrd2780_CR28","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1053\/j.gastro.2003.11.005","volume":"126","author":"JR Thiagarajah","year":"2004","unstructured":"Thiagarajah, J. R., Broadbent, T., Hsieh, E. & Verkman, A. S. Prevention of toxin-induced intestinal ion and fluid secretion by a small-molecule CFTR inhibitor. Gastroenterology 126, 511\u2013519 (2004).","journal-title":"Gastroenterology"},{"key":"BFnrd2780_CR29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399406010362","volume":"8","author":"BK Yoder","year":"2006","unstructured":"Yoder, B. K., Mulroy, S., Eustace, H., Boucher, C. & Sandford, R. Molecular pathogenesis of autosomal dominant polycystic kidney disease. Expert. Rev. Mol. Med. 8, 1\u201322 (2006).","journal-title":"Expert. Rev. Mol. Med."},{"key":"BFnrd2780_CR30","doi-asserted-by":"crossref","first-page":"148","DOI":"10.2215\/CJN.00330705","volume":"1","author":"J Grantham","year":"2006","unstructured":"Grantham, J., Chapman, A. & Torres, V. Volume progression in autosomal dominant polycystic kidney disease: the major factor determining clinical outcomes. Clin. J. Am. Soc. Nephrol. 1, 148\u2013157 (2006).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrd2780_CR31","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1681\/ASN.2007070828","volume":"19","author":"B Yang","year":"2008","unstructured":"Yang, B., Sonawane, N. D., Zhao, D., Somlo, S. & Verkman, A. S. Small-molecule CFTR inhibitors slow cyst growth in polycystic kidney disease. J. Am. Soc. Nephrol. 19, 1300\u20131310 (2008).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrd2780_CR32","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1167\/iovs.04-1314","volume":"46","author":"MH Levin","year":"2005","unstructured":"Levin, M. H. & Verkman, A. S. CFTR-regulated chloride transport at the ocular surface in living mice measured by potential differences. Invest. Opthalmol. Vis. Sci. 46, 1428\u20131434 (2005).","journal-title":"Invest. Opthalmol. Vis. Sci."},{"key":"BFnrd2780_CR33","doi-asserted-by":"crossref","first-page":"37235","DOI":"10.1074\/jbc.M205932200","volume":"277","author":"T Ma","year":"2002","unstructured":"Ma, T. et al. High-affinity activators of cystic fibrosis transmembrane conductance regulator (CFTR) chloride conductance identified by high-throughput screening. J. Biol. Chem. 277, 37235\u201337241 (2002).","journal-title":"J. Biol. Chem."},{"key":"BFnrd2780_CR34","doi-asserted-by":"crossref","first-page":"19723","DOI":"10.1074\/jbc.M101892200","volume":"276","author":"LJ Galietta","year":"2001","unstructured":"Galietta, L. J. et al. Novel CFTR chloride channel activators identified by screening of combinatorial libraries based on flavone and benzoquinolizinium lead compounds. J. Biol. Chem. 276, 19723\u201319728 (2001).","journal-title":"J. Biol. Chem."},{"key":"BFnrd2780_CR35","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/358761a0","volume":"358","author":"GM Denning","year":"1992","unstructured":"Denning, G. M. et al. Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive. Nature 358, 761\u2013764 (1992).","journal-title":"Nature"},{"key":"BFnrd2780_CR36","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/nsmb882","volume":"12","author":"K Du","year":"2005","unstructured":"Du, K., Sharma, M. & Lukacs, G. L. The DF508 cystic fibrosis mutation impairs domain-domain interactions and arrests post-translational folding of CFTR. Nature Struct. Mol. Biol. 12, 17\u201325 (2005).","journal-title":"Nature Struct. Mol. Biol."},{"key":"BFnrd2780_CR37","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/354526a0","volume":"354","author":"W Dalemans","year":"1991","unstructured":"Dalemans, W. et al. Altered chloride ion channel kinetics associated with the \u0394F508 cystic fibrosis mutation. Nature 354, 526\u2013528 (1991).","journal-title":"Nature"},{"key":"BFnrd2780_CR38","doi-asserted-by":"crossref","first-page":"C1544","DOI":"10.1152\/ajpcell.1996.270.5.C1544","volume":"270","author":"CM Haws","year":"1996","unstructured":"Haws, C. M. et al. Delta F508-CFTR channels: kinetics, activation by forskolin, and potentiation by xanthines. Am. J. Physiol. 270, C1544\u2013C1555 (1996).","journal-title":"Am. J. Physiol."},{"key":"BFnrd2780_CR39","doi-asserted-by":"crossref","first-page":"3886","DOI":"10.1128\/MCB.11.8.3886","volume":"11","author":"RJ Gregory","year":"1991","unstructured":"Gregory, R. J. et al. Maturation and function of cystic fibrosis transmembrane conductance regulator variants bearing mutations in putative nucleotide-binding domains 1 and 2. Mol. Cell. Biol. 11, 3886\u20133893 (1991).","journal-title":"Mol. Cell. Biol."},{"key":"BFnrd2780_CR40","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/humu.10041","volume":"19","author":"JL Bobadilla","year":"2002","unstructured":"Bobadilla, J. L., Macek, M. Jr., Fine, J. P. & Farrell, P. M. Cystic fibrosis: a worldwide analysis of CFTR mutations \u2014 correlation with incidence data and application to screening. Hum. Mutat. 19, 575\u2013606 (2002).","journal-title":"Hum. Mutat."},{"key":"BFnrd2780_CR41","doi-asserted-by":"crossref","first-page":"S215","DOI":"10.1152\/physrev.1999.79.1.S215","volume":"79","author":"JM Pilewski","year":"1999","unstructured":"Pilewski, J. M. & Frizzell, R. A. Role of CFTR in airway disease. Physiol. Rev. 79, S215\u2013S255 (1999).","journal-title":"Physiol. Rev."},{"key":"BFnrd2780_CR42","doi-asserted-by":"crossref","first-page":"C2","DOI":"10.1152\/ajpcell.00417.2002","volume":"284","author":"AS Verkman","year":"2005","unstructured":"Verkman, A. S., Song, Y. & and Thiagarajah, J. Role of airway surface liquid and submucosal glands in cystic fibrosis lung disease. Am. J. Physiol. 284, C2\u2013C15 (2005).","journal-title":"Am. J. Physiol."},{"key":"BFnrd2780_CR43","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1365-2796.2006.01744.x","volume":"261","author":"RC Boucher","year":"2007","unstructured":"Boucher, R. C. Evidence for airway surface dehydration as the initiating event in CF airway disease. J. Intern. Med. 261, 5\u201316 (2007).","journal-title":"J. Intern. Med."},{"key":"BFnrd2780_CR44","doi-asserted-by":"publisher","first-page":"35079","DOI":"10.1074\/jbc.M303098200","volume":"278","author":"H Yang","year":"2003","unstructured":"Yang, H. et al. Nanomolar affinity small molecule correctors of defective \u0394F508-CFTR chloride channel gating. J. Biol. Chem. 278, 35079\u201335085 (2003).","journal-title":"J. Biol. Chem."},{"key":"BFnrd2780_CR45","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1124\/mol.105.010959","volume":"67","author":"N Pedemonte","year":"2005","unstructured":"Pedemonte, N. et al. Phenylglycine and sulfonamide correctors of defective \u0394F508 and G551D cystic fibrosis transmembrane conductance regulator chloride-channel gating. Mol. Pharmacol. 67, 1797\u20131807 (2005).","journal-title":"Mol. Pharmacol."},{"key":"BFnrd2780_CR46","first-page":"L1117","volume":"290","author":"F Van Goor","year":"2006","unstructured":"Van Goor, F. et al. Rescue of \u0394F508-CFTR trafficking and gating in human cystic fibrosis airway primary cultures by small molecules. Am. J. Physiol. 290, L1117\u2013L1130 (2006).","journal-title":"Am. J. Physiol."},{"key":"BFnrd2780_CR47","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1126\/science.1093941","volume":"304","author":"ME Egan","year":"2004","unstructured":"Egan, M. E. et al. Curcumin, a major constituent of turmeric, corrects cystic fibrosis defects. Science 304, 600\u2013602 (2004).","journal-title":"Science"},{"key":"BFnrd2780_CR48","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/j.febslet.2006.03.010","volume":"580","author":"C Norez","year":"2006","unstructured":"Norez, C. et al. Rescue of functional \u0394F508-CFTR channels in cystic fibrosis epithelial cells by the \u03b1-glucosidase inhibitor miglustat. FEBS Lett. 580, 2081\u20132086 (2006).","journal-title":"FEBS Lett."},{"key":"BFnrd2780_CR49","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1136\/thx.2003.019778","volume":"60","author":"RL Dormer","year":"2005","unstructured":"Dormer, R. L. et al. Sildenafil (Viagra) corrects \u0394F508-CFTR location in nasal epithelial cells from patients with cystic fibrosis. Thorax 60, 55\u201359 (2005).","journal-title":"Thorax"},{"key":"BFnrd2780_CR50","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1164\/rccm.200703-344OC","volume":"177","author":"B Lubamba","year":"2008","unstructured":"Lubamba, B. et al. Preclinical evidence that sildenafil and vardenafil activate chloride transport in cystic fibrosis. Am. J. Respir. Crit. Care Med. 177, 506\u2013515 (2008).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"BFnrd2780_CR51","doi-asserted-by":"crossref","first-page":"5221","DOI":"10.1074\/jbc.M412972200","volume":"280","author":"A Berger","year":"2005","unstructured":"Berger, A. et al. Curcumin stimulates cystic fibrosis transmembrane conductance regulator Cl\u2212 channel activity. J. Biol. Chem. 280, 5221\u20135226 (2005).","journal-title":"J. Biol. Chem."},{"key":"BFnrd2780_CR52","doi-asserted-by":"crossref","first-page":"40629","DOI":"10.1074\/jbc.M407308200","volume":"279","author":"Y Song","year":"2004","unstructured":"Song, Y. et al. Evidence against the rescue of defective \u0394F508-CFTR cellular processing by curcumin in cell culture and mouse models. J. Biol. Chem. 279, 40629\u201340633 (2004).","journal-title":"J. Biol. Chem."},{"key":"BFnrd2780_CR53","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.bbrc.2004.10.070","volume":"325","author":"T Loo","year":"2004","unstructured":"Loo, T., Bartlett, M. & Clarke, D. Thapsigargin or curcumin does not promote maturation of processing mutants of the ABC transporters, CFTR, and P-glycoprotein. Biochem. Biophys. Res. Commun. 325, 580\u2013585 (2004).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnrd2780_CR54","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1165\/rcmb.2005-0286OC","volume":"34","author":"B Grubb","year":"2006","unstructured":"Grubb, B. et al. SERCA pump inhibitors do not correct biosynthetic arrest of \u0394F508 CFTR in cystic fibrosis. Am. J. Respir. Cell Mol. Biol. 34, 355\u2013363 (2006).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"BFnrd2780_CR55","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1172\/JCI119788","volume":"100","author":"RC Rubenstein","year":"1997","unstructured":"Rubenstein, R. C., Egan, M. E. & Zeitlin, P. L. In vitro pharmacologic restoration of CFTR-mediated chloride transport with sodium 4-phenylbutyrate in cystic fibrosis epithelial cells containing deltaF508-CFTR. J. Clin. Invest. 100, 2457\u20132465 (1997).","journal-title":"J. Clin. Invest."},{"key":"BFnrd2780_CR56","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1006\/mthe.2002.0639","volume":"6","author":"PL Zeitlin","year":"2002","unstructured":"Zeitlin, P. L. et al. Evidence of CFTR function in cystic fibrosis after systemic administration of 4-phenylbutyrate. Mol. Ther. 6, 119\u2013126 (2002).","journal-title":"Mol. Ther."},{"key":"BFnrd2780_CR57","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1172\/JCI24898","volume":"115","author":"N Pedemonte","year":"2005","unstructured":"Pedemonte, N. et al. Small molecule correctors of defective \u0394F508-CFTR cellular processing identified by high-throughput screening. J. Clin. Invest. 115, 2564\u20132571 (2005). Identification of the first small-molecule pharmacological chaperones to correct mutant CFTR misfolding.","journal-title":"J. Clin. Invest."},{"key":"BFnrd2780_CR58","doi-asserted-by":"crossref","first-page":"6044","DOI":"10.1021\/jm800533c","volume":"51","author":"GJ Yu","year":"2008","unstructured":"Yu, G. J. et al. Potent s-cis-locked bithiazole correctors of \u0394F508-CFTR cellular processing for cystic fibrosis therapy. J. Med. Chem. 51, 6044\u20136054 (2008).","journal-title":"J. Med. Chem."},{"key":"BFnrd2780_CR59","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/ppul.20168","volume":"39","author":"M Amaral","year":"2005","unstructured":"Amaral, M. Processing of CFTR: traversing the cellular maze \u2014 how much CFTR needs to go through to avoid cystic fibrosis? Pediatr. Pulmonol. 39, 479\u2013491 (2005).","journal-title":"Pediatr. Pulmonol."},{"key":"BFnrd2780_CR60","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1056\/NEJMoa022170","volume":"349","author":"M Wilschanski","year":"2003","unstructured":"Wilschanski, M. et al. Gentamicin-induced correction of CFTR function in patients with cystic fibrosis and CFTR stop mutations. N. Engl. J. Med. 349, 1433\u20131441 (2003).","journal-title":"N. Engl. J. Med."},{"key":"BFnrd2780_CR61","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nature05756","volume":"447","author":"EM Welch","year":"2007","unstructured":"Welch, E. M. et al. PTC124 targets genetic disorders caused by nonsense mutations. Nature 447, 87\u201391 (2007).","journal-title":"Nature"},{"key":"BFnrd2780_CR62","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0140-6736(08)61168-X","volume":"372","author":"E Kerem","year":"2008","unstructured":"Kerem, E. et al. Effectiveness of PTC124 treatment of cystic fibrosis caused by nonsense mutations: a prospective phase II trial. Lancet 372, 719\u2013727 (2008). Describes Phase II data supporting possible efficacy of a read-through therapy for cystic fibrosis.","journal-title":"Lancet"},{"key":"BFnrd2780_CR63","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1146\/annurev.physiol.67.032003.154341","volume":"67","author":"C Hartzell","year":"2005","unstructured":"Hartzell, C., Putzier, I. & Arreola, J. Calcium-activated chloride channels. Annu. Rev. Physiol. 67, 719\u2013758 (2005). An excellent review of CaCCs.","journal-title":"Annu. Rev. Physiol."},{"key":"BFnrd2780_CR64","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1139\/y05-040","volume":"83","author":"N Leblanc","year":"2005","unstructured":"Leblanc, N. et al. Regulation of calcium-activated chloride channels in smooth muscle cells: a complex picture is emerging. Can. J. Physiol. Pharmacol. 83, 541\u2013556 (2005).","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"BFnrd2780_CR65","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0301-0082(99)00027-1","volume":"60","author":"S Frings","year":"2000","unstructured":"Frings, S., Reuter, D. & Kleene, S. J. Neuronal Ca2+-activated Cl\u2212 channels \u2014 homing in on an elusive channel species. Prog. Neurobiol. 60, 247\u2013289 (2000).","journal-title":"Prog. Neurobiol."},{"key":"BFnrd2780_CR66","doi-asserted-by":"crossref","first-page":"4008","DOI":"10.1073\/pnas.052692999","volume":"99","author":"H Sun","year":"2002","unstructured":"Sun, H., Tsunenari, T., Yau, K. W. & Nathans, J. The vitelliform macular dystrophy protein defines a new family of chloride channels. Proc. Natl Acad. Sci. USA 99, 4008\u20134013 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrd2780_CR67","doi-asserted-by":"crossref","first-page":"49563","DOI":"10.1074\/jbc.M308414200","volume":"278","author":"Z Qu","year":"2003","unstructured":"Qu, Z., Wei, R. W., Mann, W. & Hartzell, H. C. Two bestrophins cloned from Xenopus laevis oocytes express Ca2+-activated Cl\u2212 currents. J. Biol. Chem. 278, 49563\u201349572 (2003).","journal-title":"J. Biol. Chem."},{"key":"BFnrd2780_CR68","doi-asserted-by":"crossref","first-page":"31016","DOI":"10.1074\/jbc.270.52.31016","volume":"270","author":"SA Cunningham","year":"1995","unstructured":"Cunningham, S. A. et al. Cloning of an epithelial chloride channel from bovine trachea. J. Biol. Chem. 270, 31016\u201331026 (1995).","journal-title":"J. Biol. Chem."},{"key":"BFnrd2780_CR69","doi-asserted-by":"crossref","first-page":"20093","DOI":"10.1074\/jbc.M009376200","volume":"276","author":"P Huang","year":"2001","unstructured":"Huang, P. et al. Regulation of human CLC-3 channels by multifunctional Ca2+\/calmodulin-dependent protein kinase. J. Biol. Chem. 276, 20093\u201320100 (2001).","journal-title":"J. Biol. Chem."},{"key":"BFnrd2780_CR70","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1513\/pats.2306010","volume":"1","author":"J Eggermont","year":"2004","unstructured":"Eggermont, J. Calcium-activated chloride channels: (un)known, (un)loved? Proc. Am. Thorac. Soc. 1, 22\u201327 (2004).","journal-title":"Proc. Am. Thorac. Soc."},{"key":"BFnrd2780_CR71","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s00424-007-0245-z","volume":"454","author":"K Kunzelmann","year":"2007","unstructured":"Kunzelmann, K., Milenkovic, V. M., Spitzner, M., Soria, R. B. & Schreiber, R. Calcium-dependent chloride conductance in epithelia: is there a contribution by Bestrophin? Pflugers Arch. 454, 879\u2013889 (2007).","journal-title":"Pflugers Arch."},{"key":"BFnrd2780_CR72","doi-asserted-by":"crossref","first-page":"41114","DOI":"10.1074\/jbc.M306150200","volume":"278","author":"T Tsunenari","year":"2003","unstructured":"Tsunenari, T. et al. Structure-function analysis of the bestrophin family of anion channels. J. Biol. Chem. 278, 41114\u201341125 (2003).","journal-title":"J. Biol. Chem."},{"key":"BFnrd2780_CR73","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1085\/jgp.200409031","volume":"123","author":"Z Qu","year":"2004","unstructured":"Qu, Z., Fischmeister, R. & Hartzell, C. Mouse bestrophin-2 is a bona fide Cl\u2212 channel: identification of a residue important in anion binding and conduction. J. Gen. Physiol. 123, 327\u2013340 (2004).","journal-title":"J. Gen. Physiol."},{"key":"BFnrd2780_CR74","doi-asserted-by":"crossref","first-page":"5660","DOI":"10.1523\/JNEUROSCI.0065-08.2008","volume":"28","author":"K Yu","year":"2008","unstructured":"Yu, K., Xiao, Q., Cui, G., Lee, A. & Hartzell, H. C. The best disease-linked Cl\u2212 channel hBest1 regulates CaV1 (L-type) Ca2+ channels via src-homology-binding domains. J. Neurosci. 28, 5660\u20135670 (2008).","journal-title":"J. Neurosci."},{"key":"BFnrd2780_CR75","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1038\/nature07313","volume":"455","author":"YD Yang","year":"2008","unstructured":"Yang, Y. D. et al. TMEM16A confers receptor-activated calcium-dependent chloride conductance. Nature 455, 1210\u20131215 (2008).","journal-title":"Nature"},{"key":"BFnrd2780_CR76","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1126\/science.1163518","volume":"322","author":"A Caputo","year":"2008","unstructured":"Caputo, A. et al. TMEM16A, a membrane protein associated with calcium-dependent chloride channel activity. Science 322, 590\u2013594 (2008).","journal-title":"Science"},{"key":"BFnrd2780_CR77","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.cell.2008.09.003","volume":"134","author":"BC Schroeder","year":"2008","unstructured":"Schroeder, B. C., Cheng, T., Jan, Y. N. & Jan, L. Y. Expression cloning of TMEM16A as a calcium-activated chloride channel subunit. Cell 134, 1019\u20131029 (2008).","journal-title":"Cell"},{"key":"BFnrd2780_CR78","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1146\/annurev.physiol.62.1.535","volume":"62","author":"KE Barrett","year":"2000","unstructured":"Barrett, K. E. & Keely, S. J. Chloride secretion by the intestinal epithelium: molecular basis and regulatory aspects. Annu. Rev. Physiol. 62, 535\u2013572 (2000).","journal-title":"Annu. Rev. Physiol."},{"key":"BFnrd2780_CR79","doi-asserted-by":"crossref","first-page":"C998","DOI":"10.1152\/ajpcell.00357.2003","volume":"264","author":"PA Rufo","year":"2004","unstructured":"Rufo, P. A. et al. Diarrhea-associated HIV-1 APIs potentiate muscarinic activation of Cl\u2212 secretion by T84 cells via prolongation of cytosolic Ca2+ signaling. Am. J. Physiol. 264, C998\u2013C1008 (2004).","journal-title":"Am. J. Physiol."},{"key":"BFnrd2780_CR80","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s00232-005-0757-4","volume":"204","author":"G Schultheiss","year":"2005","unstructured":"Schultheiss, G., Siefjediers, A. & Diener, M. Muscarinic receptor stimulation activates a Ca2+-dependent Cl\u2212 conductance in rat distal colon. J. Membr. Biol. 204, 117\u2013127 (2005).","journal-title":"J. Membr. Biol."},{"key":"BFnrd2780_CR81","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1378\/chest.06-2031","volume":"131","author":"AE Hegab","year":"2007","unstructured":"Hegab, A. E. et al. Niflumic acid and AG-1478 reduce cigarette smoke-induced mucin synthesis: the role of hCLCA1. Chest 131, 1149\u20131156 (2007).","journal-title":"Chest"},{"key":"BFnrd2780_CR82","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1164\/rccm.200608-1238OC","volume":"176","author":"RR Deterding","year":"2007","unstructured":"Deterding, R. R. et al. Phase 2 randomized safety and efficacy trial of nebulized denufosol tetrasodium in cystic fibrosis. Am. J. Respir. Crit. Care Med. 176, 362\u2013369 (2007).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"BFnrd2780_CR83","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1378\/chest.06-2085","volume":"131","author":"H Grasemann","year":"2007","unstructured":"Grasemann, H. et al. Inhalation of Moli1901 in patients with cystic fibrosis. Chest 131, 1461\u20131466 (2007).","journal-title":"Chest"},{"key":"BFnrd2780_CR84","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/348510a0","volume":"348","author":"TJ Jentsch","year":"1990","unstructured":"Jentsch, T. J., Steinmeyer, K. & Schwarz, G. Primary structure of Torpedo marmorata chloride channel isolated by expression cloning in Xenopus oocytes. Nature 348, 510\u2013514 (1990). Describes the original cloning of a ClC-type chloride channel.","journal-title":"Nature"},{"key":"BFnrd2780_CR85","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nature02314","volume":"427","author":"A Accardi","year":"2004","unstructured":"Accardi, A. & Miller, C. Secondary active transport mediated by a prokaryotic homologue of ClC Cl\u2212 channels. Nature 427, 803\u2013807 (2004). Demonstration that a ClC-type protein functions as an electrogenic Cl\u2212\/H+ antiporter. This mechanism of transport was later found in eukaryotic intracellular ClCs.","journal-title":"Nature"},{"key":"BFnrd2780_CR86","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/nature03860","volume":"436","author":"O Scheel","year":"2005","unstructured":"Scheel, O., Zdebik, A. A., Lourdel, S. & Jentsch, T. J. Voltage-dependent electrogenic chloride\/proton exchange by endosomal CLC proteins. Nature 436, 424\u2013427 (2005).","journal-title":"Nature"},{"key":"BFnrd2780_CR87","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nature03720","volume":"436","author":"A Picollo","year":"2005","unstructured":"Picollo, A. & Pusch, M. Chloride\/proton antiporter activity of mammalian CLC proteins ClC-4 and ClC-5. Nature 436, 420\u2013423 (2005).","journal-title":"Nature"},{"key":"BFnrd2780_CR88","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/nature06907","volume":"453","author":"AR Graves","year":"2008","unstructured":"Graves, A. R., Curran, P. K., Smith, C. L. & Mindell, J. A. The Cl\u2212\/H+ antiporter ClC-7 is the primary chloride permeation pathway in lysosomes. Nature 453, 788\u2013792 (2008).","journal-title":"Nature"},{"key":"BFnrd2780_CR89","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/415287a","volume":"415","author":"R Dutzler","year":"2002","unstructured":"Dutzler, R., Campbell, E. B., Cadene, M., Chait, B. T. & MacKinnon, R. X-ray structure of a ClC chloride channel at 3.0 \u00c5 reveals the molecular basis of anion selectivity. Nature 415, 287\u2013294 (2002).","journal-title":"Nature"},{"key":"BFnrd2780_CR90","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nature04713","volume":"440","author":"C Miller","year":"2006","unstructured":"Miller, C. ClC chloride channels viewed through a transporter lens. Nature 440, 484\u2013489 (2006).","journal-title":"Nature"},{"key":"BFnrd2780_CR91","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1073\/pnas.81.9.2772","volume":"81","author":"C Miller","year":"1984","unstructured":"Miller, C. & White, M. M. Dimeric structure of single chloride channels from Torpedo electroplax. Proc. Natl Acad. Sci. USA 81, 2772\u20132775 (1984).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrd2780_CR92","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/383340a0","volume":"383","author":"U Ludewig","year":"1996","unstructured":"Ludewig, U., Pusch, M. & Jentsch, T. J. Two physically distinct pores in the dimeric ClC-0 chloride channel. Nature 383, 340\u2013343 (1996).","journal-title":"Nature"},{"key":"BFnrd2780_CR93","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1085\/jgp.113.3.457","volume":"113","author":"C Saviane","year":"1999","unstructured":"Saviane, C., Conti, F. & Pusch, M. The muscle chloride channel ClC-1 has a double-barreled appearance that is differentially affected in dominant and recessive myotonia. J. Gen. Physiol. 113, 457\u2013468 (1999).","journal-title":"J. Gen. Physiol."},{"key":"BFnrd2780_CR94","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1074\/jbc.M005733200","volume":"276","author":"F Weinreich","year":"2001","unstructured":"Weinreich, F. & Jentsch, T. J. Pores formed by single subunits in mixed dimers of different CLC chloride channels. J. Biol. Chem. 276, 2347\u20132353 (2001).","journal-title":"J. Biol. Chem."},{"key":"BFnrd2780_CR95","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1113\/jphysiol.2003.058453","volume":"557","author":"R Est\u00e9vez","year":"2004","unstructured":"Est\u00e9vez, R., Pusch, M., Ferrer-Costa, C., Orozco, M. & Jentsch, T. J. Functional and structural conservation of CBS domains from CLC chloride channels. J. Physiol. 557, 363\u2013378 (2004).","journal-title":"J. Physiol."},{"key":"BFnrd2780_CR96","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1113\/jphysiol.2006.124719","volume":"578","author":"TJ Jentsch","year":"2007","unstructured":"Jentsch, T. J. Chloride and the endosomal-lysosomal pathway: emerging roles of CLC chloride transporters. J. Physiol. 578, 633\u2013640 (2007).","journal-title":"J. Physiol."},{"key":"BFnrd2780_CR97","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1113\/jphysiol.1996.sp021778","volume":"497","author":"GY Rychkov","year":"1996","unstructured":"Rychkov, G. Y. et al. Concentration and pH dependence of skeletal muscle chloride channel ClC-1. J. Physiol. 497, 423\u2013435 (1996).","journal-title":"J. Physiol."},{"key":"BFnrd2780_CR98","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/373527a0","volume":"373","author":"M Pusch","year":"1995","unstructured":"Pusch, M., Ludewig, U., Rehfeldt, A. & Jentsch, T. J. Gating of the voltage-dependent chloride channel CIC-0 by the permeant anion. Nature 373, 527\u2013531 (1995).","journal-title":"Nature"},{"key":"BFnrd2780_CR99","doi-asserted-by":"crossref","first-page":"27635","DOI":"10.1016\/S0021-9258(18)47032-9","volume":"269","author":"R Klocke","year":"1994","unstructured":"Klocke, R., Steinmeyer, K., Jentsch, T. J. & Jockusch, H. Role of innervation, excitability, and myogenic factors in the expression of the muscular chloride channel ClC-1. A study on normal and myotonic muscle. J. Biol. Chem. 269, 27635\u201327639 (1994).","journal-title":"J. Biol. Chem."},{"key":"BFnrd2780_CR100","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/humu.10063","volume":"19","author":"M Pusch","year":"2002","unstructured":"Pusch, M. Myotonia caused by mutations in the muscle chloride channel gene CLCN1. Hum. Mutat. 19, 423\u2013434 (2002).","journal-title":"Hum. Mutat."},{"key":"BFnrd2780_CR101","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S1097-2765(02)00572-5","volume":"10","author":"N Charlet-B","year":"2002","unstructured":"Charlet-B, N. et al. Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing. Mol. Cell 10, 45\u201353 (2002).","journal-title":"Mol. Cell"},{"key":"BFnrd2780_CR102","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1097-2765(02)00563-4","volume":"10","author":"A Mankodi","year":"2002","unstructured":"Mankodi, A. et al. Expanded CUG repeats trigger aberrant splicing of ClC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy. Mol. Cell 10, 35\u201344 (2002).","journal-title":"Mol. Cell"},{"key":"BFnrd2780_CR103","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/356057a0","volume":"356","author":"A Thiemann","year":"1992","unstructured":"Thiemann, A., Gr\u00fcnder, S., Pusch, M. & Jentsch, T. J. A chloride channel widely expressed in epithelial and non-epithelial cells. Nature 356, 57\u201360 (1992).","journal-title":"Nature"},{"key":"BFnrd2780_CR104","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/360759a0","volume":"360","author":"S Gr\u00fcnder","year":"1992","unstructured":"Gr\u00fcnder, S., Thiemann, A., Pusch, M. & Jentsch, T. J. Regions involved in the opening of CIC-2 chloride channel by voltage and cell volume. Nature 360, 759\u2013762 (1992).","journal-title":"Nature"},{"key":"BFnrd2780_CR105","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0896-6273(00)80186-5","volume":"17","author":"K Staley","year":"1996","unstructured":"Staley, K., Smith, R., Schaack, J., Wilcox, C. & Jentsch, T. J. Alteration of GABAA receptor function following gene transfer of the CLC-2 chloride channel. Neuron 17, 543\u2013551 (1996).","journal-title":"Neuron"},{"key":"BFnrd2780_CR106","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/emboj\/20.6.1289","volume":"20","author":"MR B\u00f6sl","year":"2001","unstructured":"B\u00f6sl, M. R. et al. Male germ cells and photoreceptors, both dependent on close cell-cell interactions, degenerate upon ClC-2 Cl\u2212 channel disruption. EMBO J. 20, 1289\u20131299 (2001).","journal-title":"EMBO J."},{"key":"BFnrd2780_CR107","doi-asserted-by":"crossref","first-page":"6581","DOI":"10.1523\/JNEUROSCI.0338-07.2007","volume":"27","author":"J Blanz","year":"2007","unstructured":"Blanz, J. et al. Leukoencephalopathy upon disruption of the chloride channel ClC-2. J. Neurosci. 27, 6581\u20136589 (2007).","journal-title":"J. Neurosci."},{"key":"BFnrd2780_CR108","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/ng1121","volume":"33","author":"K Haug","year":"2003","unstructured":"Haug, K. et al. Mutations in CLCN2 encoding a voltage-gated chloride channel are associated with idiopathic generalized epilepsies. Nature Genet. 33, 527\u2013532 (2003).","journal-title":"Nature Genet."},{"key":"BFnrd2780_CR109","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1152\/physiolgenomics.00070.2004","volume":"19","author":"MI Niemeyer","year":"2004","unstructured":"Niemeyer, M. I. et al. Functional evaluation of human ClC-2 chloride channel mutations associated with idiopathic generalized epilepsies. Physiol. Genomics 19, 74\u201383 (2004).","journal-title":"Physiol. Genomics"},{"key":"BFnrd2780_CR110","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/ncpneph0689","volume":"4","author":"BK Kr\u00e4mer","year":"2008","unstructured":"Kr\u00e4mer, B. K., Bergler, T., Stoelcker, B. & Waldegger, S. Mechanisms of disease: the kidney-specific chloride channels ClCKA and ClCKB, the Barttin subunit, and their clinical relevance. Nature Clin. Pract. Nephrol. 4, 38\u201346 (2008).","journal-title":"Nature Clin. Pract. Nephrol."},{"key":"BFnrd2780_CR111","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/ng1097-171","volume":"17","author":"DB Simon","year":"1997","unstructured":"Simon, D. B. et al. Mutations in the chloride channel gene, CLCNKB, cause Bartter's syndrome type III. Nature Genet. 17, 171\u2013178 (1997).","journal-title":"Nature Genet."},{"key":"BFnrd2780_CR112","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/5036","volume":"21","author":"Y Matsumura","year":"1999","unstructured":"Matsumura, Y. et al. Overt nephrogenic diabetes insipidus in mice lacking the CLC-K1 chloride channel. Nature Genet. 21, 95\u201398 (1999).","journal-title":"Nature Genet."},{"key":"BFnrd2780_CR113","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/35107099","volume":"414","author":"R Est\u00e9vez","year":"2001","unstructured":"Est\u00e9vez, R. et al. Barttin is a Cl\u2212 channel beta-subunit crucial for renal Cl\u2212 reabsorption and inner ear K+ secretion. Nature 414, 558\u2013561 (2001).","journal-title":"Nature"},{"key":"BFnrd2780_CR114","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/ng752","volume":"29","author":"R Birkenh\u00e4ger","year":"2001","unstructured":"Birkenh\u00e4ger, R. et al. Mutation of BSND causes Bartter syndrome with sensorineural deafness and kidney failure. Nature Genet. 29, 310\u2013314 (2001).","journal-title":"Nature Genet."},{"key":"BFnrd2780_CR115","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1161\/01.HYP.0000129824.12959.f0","volume":"43","author":"N Jeck","year":"2004","unstructured":"Jeck, N. et al. Activating mutation of the renal epithelial chloride channel ClC-Kb predisposing to hypertension. Hypertension 43, 1175\u20131181 (2004).","journal-title":"Hypertension"},{"key":"BFnrd2780_CR116","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1523-1755.2004.00363.x","volume":"65","author":"N Jeck","year":"2004","unstructured":"Jeck, N., Waldegger, P., Doroszewicz, J., Seyberth, H. & Waldegger, S. A common sequence variation of the CLCNKB gene strongly activates ClC-Kb chloride channel activity. Kidney Int. 65, 190\u2013197 (2004).","journal-title":"Kidney Int."},{"key":"BFnrd2780_CR117","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1093\/hmg\/ddm112","volume":"16","author":"C Barlassina","year":"2007","unstructured":"Barlassina, C. et al. Common genetic variants and haplotypes in renal CLCNKA gene are associated to salt-sensitive hypertension. Hum. Mol. Genet. 16, 1630\u20131638 (2007).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrd2780_CR118","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/379445a0","volume":"379","author":"SE Lloyd","year":"1996","unstructured":"Lloyd, S. E. et al. A common molecular basis for three inherited kidney stone diseases. Nature 379, 445\u2013449 (1996).","journal-title":"Nature"},{"key":"BFnrd2780_CR119","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1007\/s00424-002-0950-6","volume":"445","author":"W G\u00fcnther","year":"2003","unstructured":"G\u00fcnther, W., Piwon, N. & Jentsch, T. J. The ClC-5 chloride channel knock-out mouse \u2014 an animal model for Dent's disease. Pflugers Arch. 445, 456\u2013462 (2003). .","journal-title":"Pflugers Arch."},{"key":"BFnrd2780_CR120","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/35042597","volume":"408","author":"N Piwon","year":"2000","unstructured":"Piwon, N., G\u00fcnther, W., Schwake, M., B\u00f6sl, M. R. & Jentsch, T. J. ClC-5 Cl\u2212 channel disruption impairs endocytosis in a mouse model for Dent's disease. Nature 408, 369\u2013373 (2000).","journal-title":"Nature"},{"key":"BFnrd2780_CR121","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0092-8674(01)00206-9","volume":"104","author":"U Kornak","year":"2001","unstructured":"Kornak, U. et al. Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man. Cell 104, 205\u2013215 (2001).","journal-title":"Cell"},{"key":"BFnrd2780_CR122","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1124\/mol.58.3.498","volume":"58","author":"M Pusch","year":"2000","unstructured":"Pusch, M. et al. Pharmacological characterization of chloride channels belonging to the ClC family by the use of chiral clofibric acid derivatives. Mol. Pharmacol. 58, 498\u2013507 (2000).","journal-title":"Mol. Pharmacol."},{"key":"BFnrd2780_CR123","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0896-6273(03)00168-5","volume":"38","author":"R Est\u00e9vez","year":"2003","unstructured":"Est\u00e9vez, R., Schroeder, B. C., Accardi, A., Jentsch, T. J. & Pusch M. Conservation of chloride channel structure revealed by an inhibitor binding site in ClC-1. Neuron 38, 47\u201359 (2003).","journal-title":"Neuron"},{"key":"BFnrd2780_CR124","doi-asserted-by":"crossref","first-page":"C500","DOI":"10.1152\/ajpcell.1998.274.2.C500","volume":"274","author":"T Furukawa","year":"1998","unstructured":"Furukawa, T., Ogura, T., Katayama, Y. & Hiraoka, M. Characteristics of rabbit ClC-2 current expressed in Xenopus oocytes and its contribution to volume regulation. Am. J. Physiol. 274, C500\u2013C512 (1998).","journal-title":"Am. J. Physiol."},{"key":"BFnrd2780_CR125","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1469-7793.1998.665bv.x","volume":"506","author":"S Clark","year":"1998","unstructured":"Clark, S., Jordt, S. E., Jentsch, T. J. & Mathie, A. Characterization of the hyperpolarization-activated chloride current in dissociated rat sympathetic neurons. J. Physiol. 506, 665\u2013678 (1998).","journal-title":"J. Physiol."},{"key":"BFnrd2780_CR126","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/sj.embor.7400169","volume":"5","author":"A Picollo","year":"2004","unstructured":"Picollo, A. et al. Molecular determinants of differential pore blocking of kidney CLC-K chloride channels. EMBO Rep. 5, 584\u2013589 (2004).","journal-title":"EMBO Rep."},{"key":"BFnrd2780_CR127","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1073\/pnas.0708977105","volume":"105","author":"A Liantonio","year":"2008","unstructured":"Liantonio, A. et al. Molecular switch for CLC-K Cl\u2212 channel block\/activation: optimal pharmacophoric requirements towards high-affinity ligands. Proc. Natl Acad. Sci. USA 105, 1369\u20131373 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrd2780_CR128","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1124\/mol.105.017384","volume":"69","author":"A Liantonio","year":"2006","unstructured":"Liantonio, A. et al. Activation and inhibition of kidney CLC-K chloride channels by fenamates. Mol. Pharmacol. 69, 165\u2013173 (2006).","journal-title":"Mol. Pharmacol."},{"key":"BFnrd2780_CR129","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1358\/dnp.2005.18.8.944546","volume":"18","author":"S Schaller","year":"2005","unstructured":"Schaller, S., Henriksen, K., S\u00f8rensen, M. G. & Karsdal, M. A. The role of chloride channels in osteoclasts: ClC-7 as a target for osteoporosis treatment. Drug News Perspect. 18, 489\u2013495 (2005).","journal-title":"Drug News Perspect."},{"key":"BFnrd2780_CR130","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1359\/JBMR.040302","volume":"19","author":"S Schaller","year":"2004","unstructured":"Schaller, S. et al. The chloride channel inhibitor NS3736 prevents bone resorption in ovariectomized rats without changing bone formation. J. Bone Miner. Res. 19, 1144\u20131153 (2004).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrd2780_CR131","doi-asserted-by":"crossref","first-page":"C1173","DOI":"10.1152\/ajpcell.00528.2003","volume":"287","author":"J Cuppoletti","year":"2004","unstructured":"Cuppoletti, J. et al. SPI-0211 activates T84 cell chloride transport and recombinant human ClC-2 chloride currents. Am. J. Physiol. 287, C1173\u2013C1183 (2004).","journal-title":"Am. J. Physiol."},{"key":"BFnrd2780_CR132","doi-asserted-by":"crossref","first-page":"4243","DOI":"10.1242\/jcs.02525","volume":"118","author":"G Pe\u00f1a-M\u00fcnzenmayer","year":"2005","unstructured":"Pe\u00f1a-M\u00fcnzenmayer, G. et al. Basolateral localization of native ClC-2 chloride channels in absorptive intestinal epithelial cells and basolateral sorting encoded by a CBS-2 domain di-leucine motif. J. Cell Sci. 118, 4243\u20134252 (2005).","journal-title":"J. Cell Sci."},{"key":"BFnrd2780_CR133","doi-asserted-by":"crossref","first-page":"C1787","DOI":"10.1152\/ajpcell.2000.279.6.C1787","volume":"279","author":"K Gy\u00f6m\u00f6rey","year":"2000","unstructured":"Gy\u00f6m\u00f6rey, K., Yeger, H., Ackerley, C., Garami, E. & Bear, C. E. Expression of the chloride channel ClC-2 in the murine small intestine epithelium. Am. J. Physiol. 279, C1787\u2013C1794 (2000).","journal-title":"Am. J. Physiol."},{"key":"BFnrd2780_CR134","doi-asserted-by":"crossref","first-page":"22276","DOI":"10.1074\/jbc.M309899200","volume":"279","author":"AA Zdebik","year":"2004","unstructured":"Zdebik, A. A., Cuffe, J. E., Bertog, M., Korbmacher, C. & Jentsch, T. J. Additional disruption of the ClC-2 Cl\u2212 channel does not exacerbate the cystic fibrosis phenotype of cystic fibrosis transmembrane conductance regulator mouse models. J. Biol. Chem. 279, 22276\u201322283 (2004).","journal-title":"J. Biol. Chem."},{"key":"BFnrd2780_CR135","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1111\/j.1365-2036.2007.03320.x","volume":"25","author":"JF Johanson","year":"2007","unstructured":"Johanson, J. F. & Ueno, R. Lubiprostone, a locally acting chloride channel activator, in adult patients with chronic constipation: a double-blind, placebo-controlled, dose-ranging study to evaluate efficacy and safety. Aliment. Pharmacol. Ther. 25, 1351\u20131361 (2007).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"BFnrd2780_CR136","first-page":"G234","volume":"295","author":"HF Bao","year":"2008","unstructured":"Bao, H. F. et al. A synthetic prostone activates apical chloride channels in A6 epithelial cells. Am. J. Physiol. 295, G234\u2013G251 (2008).","journal-title":"Am. J. Physiol."},{"key":"BFnrd2780_CR137","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1152\/physrev.00042.2003","volume":"84","author":"JW Lynch","year":"2004","unstructured":"Lynch, J. W. Molecular structure and function of the glycine receptor chloride channel. Physiol. Rev. 84, 1051\u20131095, (2004).","journal-title":"Physiol. Rev."},{"key":"BFnrd2780_CR138","doi-asserted-by":"crossref","first-page":"E353","DOI":"10.1007\/BF02854906","volume":"8","author":"M Cascio","year":"2006","unstructured":"Cascio, M. Modulating inhibitory ligand-gated ion channels. AAPS J. 8, E353\u2013E361 (2006).","journal-title":"AAPS J."},{"key":"BFnrd2780_CR139","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1038\/sj.bjp.0706443","volume":"147","author":"NG Bowery","year":"2006","unstructured":"Bowery, N. G. & Smart, T. G. GABA and glycine as neurotransmitters: a brief history. Br. J. Pharmacol. 147, S109\u2013S119 (2006).","journal-title":"Br. J. Pharmacol."},{"key":"BFnrd2780_CR140","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.2174\/138161207781368693","volume":"13","author":"TI Webb","year":"2007","unstructured":"Webb, T. I. & Lynch, J. W. Molecular pharmacology of the glycine receptor chloride channel. Curr. Pharm. Des. 13, 2350\u20132367 (2007).","journal-title":"Curr. Pharm. Des."},{"key":"BFnrd2780_CR141","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1042\/bst0320540","volume":"32","author":"TL Kash","year":"2004","unstructured":"Kash, T. L., Trudell, J. R. & Harrison, N. L. Structural elements involved in activation of the \u03b3-aminobutyric acid type A (GABAA) receptor. Biochem. Soc. Trans. 32, 540\u2013546 (2004).","journal-title":"Biochem. Soc. Trans."},{"key":"BFnrd2780_CR142","doi-asserted-by":"crossref","first-page":"8069","DOI":"10.1523\/JNEUROSCI.20-21-08069.2000","volume":"20","author":"RA DeFazio","year":"2000","unstructured":"DeFazio, R. A., Keros, S., Quick, M. W. & Hablitz, J. J. Potassium-coupled chloride cotransport controls intracellular chloride in rat neocortical pyramidal neurons. J. Neurosci. 20, 8069\u20138076 (2000).","journal-title":"J. Neurosci."},{"key":"BFnrd2780_CR143","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0896-6273(01)00297-5","volume":"30","author":"CA H\u00fcbner","year":"2001","unstructured":"H\u00fcbner, C. A. et al. Disruption of KCC2 reveals an essential role of K-Cl cotransport already in early synaptic inhibition. Neuron 30, 515\u2013524 (2001).","journal-title":"Neuron"},{"key":"BFnrd2780_CR144","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/ng1293-351","volume":"5","author":"R Shiang","year":"1993","unstructured":"Shiang, R. et al. Point mutations in the gene encoding the \u03b1-1 subunit of the inhibitory glycine receptor cause the dominant neurologic disorder, hyperekplexia. Nature Genet. 5, 351\u2013357 (1993).","journal-title":"Nature Genet."},{"key":"BFnrd2780_CR145","first-page":"46","volume":"28","author":"S Baulac","year":"2001","unstructured":"Baulac, S. et al. First genetic evidence of GABAA receptor dysfunction in epilepsy: a mutation in the \u03b3-2-subunit gene. Nature Genet. 28, 46\u201348 (2001).","journal-title":"Nature Genet."},{"key":"BFnrd2780_CR146","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/ng885","volume":"31","author":"P Cossette","year":"2002","unstructured":"Cossette, P. et al. Mutation of GABRA1 in an autosomal dominant form of juvenile myoclonic epilepsy. Nature Genet. 31, 184\u2013189 (2002).","journal-title":"Nature Genet."},{"key":"BFnrd2780_CR147","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/ana.20874","volume":"59","author":"S Maljevic","year":"2006","unstructured":"Maljevic, S. et al. A mutation in the GABAA receptor \u03b11-subunit is associated with absence epilepsy. Ann. Neurol. 59, 983\u2013987 (2006).","journal-title":"Ann. Neurol."},{"key":"BFnrd2780_CR148","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1002\/ana.10696","volume":"54","author":"CG Wong","year":"2003","unstructured":"Wong, C. G., Bottiglieri, T. & Snead, O. C. GABA, gamma-hydroxybutyric acid, and neurological disease. Ann. Neurol. 54, S3\u2013S12 (2003).","journal-title":"Ann. Neurol."},{"key":"BFnrd2780_CR149","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1021\/jm031076j","volume":"47","author":"F Sternfeld","year":"2004","unstructured":"Sternfeld, F. et al. Selective, orally active \u03b3-aminobutyric acidA \u03b1-5 receptor inverse agonists as cognition enhancers. J. Med. Chem. 47, 2176\u20132179 (2004).","journal-title":"J. Med. Chem."},{"key":"BFnrd2780_CR150","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.coph.2005.10.004","volume":"6","author":"KA Wafford","year":"2006","unstructured":"Wafford, K. A. & Ebert, B. Gaboxadol \u2014 a new awakening in sleep. Curr. Opin. Pharmacol. 6, 30\u201336 (2006).","journal-title":"Curr. Opin. Pharmacol."},{"key":"BFnrd2780_CR151","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/j.1440-1681.2004.04083.x","volume":"31","author":"M Chebib","year":"2004","unstructured":"Chebib, M. GABAC receptor ion channels. Clin. Exp. Pharmacol. Physiol. 31, 800\u2013804 (2004).","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"BFnrd2780_CR152","doi-asserted-by":"crossref","first-page":"260","DOI":"10.2174\/1568007033482805","volume":"2","author":"GA Johnston","year":"2003","unstructured":"Johnston, G. A., Chebib, M., Hanrahan, J. R. & Mewett, K. N. GABAC receptors as drug targets. Curr. Drug Targets CNS Neurol. Disord. 2, 260\u2013268 (2003).","journal-title":"Curr. Drug Targets CNS Neurol. Disord."},{"key":"BFnrd2780_CR153","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1126\/science.1094925","volume":"304","author":"RJ Harvey","year":"2004","unstructured":"Harvey, R. J. et al. GlyR \u03b13: an essential target for spinal PGE2-mediated inflammatory pain sensitization. Science 304, 884\u2013887 (2004).","journal-title":"Science"},{"key":"BFnrd2780_CR154","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0022-3565(24)29665-8","volume":"296","author":"JH Ye","year":"2001","unstructured":"Ye, J. H. et al. Ethanol potentiation of glycine-induced responses in dissociated neurons of rat ventral tegmental area. J. Pharmacol. Exp. Ther. 296, 77\u201383 (2001).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BFnrd2780_CR155","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0026-895X(24)23230-2","volume":"57","author":"MJ Beckstead","year":"2000","unstructured":"Beckstead, M. J., Weiner, J. L., Eger, E. I., Gong, D. H. & Mihic, S. J. Glycine and \u03b3-aminobutyric acidA receptor function is enhanced by inhaled drugs of abuse. Mol. Pharmacol. 57, 1199\u20131205 (2000).","journal-title":"Mol. Pharmacol."},{"key":"BFnrd2780_CR156","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/sj.bjp.0704775","volume":"136","author":"L Tao","year":"2002","unstructured":"Tao, L. & Ye, J. H. Inhibition of glycine receptor function of native neurons by aliphatic n-alcohols. Br. J. Pharmacol. 136, 629\u2013635 (2002).","journal-title":"Br. J. Pharmacol."},{"key":"BFnrd2780_CR157","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1748-1716.2006.01537.x","volume":"187","author":"A Stutzin","year":"2006","unstructured":"Stutzin, A. & Hoffmann, E. K. Swelling-activated ion channels: functional regulation in cell-swelling, proliferation and apoptosis. Acta Physiol. (Oxf) 187, 27\u201342 (2006).","journal-title":"Acta Physiol. (Oxf)"},{"key":"BFnrd2780_CR158","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1113\/jphysiol.1992.sp019340","volume":"456","author":"M Kubo","year":"1992","unstructured":"Kubo, M. & Okada, Y. Volume-regulatory Cl\u2212 channel currents in cultured human epithelial cells. J. Physiol. 456, 351\u2013371 (1992).","journal-title":"J. Physiol."},{"key":"BFnrd2780_CR159","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1085\/jgp.105.5.661","volume":"105","author":"PS Jackson","year":"1995","unstructured":"Jackson, P. S. & Strange, K. Characterization of the voltage-dependent properties of a volume-sensitive anion conductance. J. Gen. Physiol. 105, 661\u2013676 (1995).","journal-title":"J. Gen. Physiol."},{"key":"BFnrd2780_CR160","doi-asserted-by":"crossref","first-page":"C755","DOI":"10.1152\/ajpcell.1997.273.3.C755","volume":"273","author":"Y Okada","year":"1997","unstructured":"Okada, Y. Volume expansion-sensing outward-rectifier Cl\u2212 channel: fresh start to the molecular identity and volume sensor. Am. J. Physiol. 273, C755\u2013C789 (1997).","journal-title":"Am. J. Physiol."},{"key":"BFnrd2780_CR161","doi-asserted-by":"crossref","first-page":"C1489","DOI":"10.1152\/ajpcell.1993.265.6.C1489","volume":"265","author":"PS Jackson","year":"1993","unstructured":"Jackson, P. S. & Strange, K. Volume-sensitive anion channels mediate swelling-activated inositol and taurine efflux. Am. J. Physiol. 265, C1489\u2013C1500 (1993).","journal-title":"Am. J. Physiol."},{"key":"BFnrd2780_CR162","doi-asserted-by":"crossref","first-page":"C1703","DOI":"10.1152\/ajpcell.1996.270.6.C1703","volume":"270","author":"R S\u00e1nchez-Olea","year":"1996","unstructured":"S\u00e1nchez-Olea, R., Morales, M., Garc\u00eda, O. & Pasantes-Morales, H. Cl\u2212 channel blockers inhibit the volume-activated efflux of Cl\u2212 and taurine in cultured neurons. Am. J. Physiol. 270, C1703\u2013C1708 (1996).","journal-title":"Am. J. Physiol."},{"key":"BFnrd2780_CR163","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000113743","volume":"21","author":"DB Shennan","year":"2008","unstructured":"Shennan, D. B. Swelling-induced taurine transport: relationship with chloride channels, anion-exchangers and other swelling-activated transport pathways. Cell Physiol. Biochem. 21, 15\u201328 (2008).","journal-title":"Cell Physiol. Biochem."},{"key":"BFnrd2780_CR164","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/355830a0","volume":"355","author":"MA Valverde","year":"1992","unstructured":"Valverde, M. A. et al. Volume-regulated chloride channels associated with the human multidrug-resistance P-glycoprotein. Nature 355, 830\u2013833 (1992).","journal-title":"Nature"},{"key":"BFnrd2780_CR165","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/356238a0","volume":"356","author":"M Paulmichl","year":"1992","unstructured":"Paulmichl, M. et al. New mammalian chloride channel identified by expression cloning. Nature 356, 238\u2013241 (1992).","journal-title":"Nature"},{"key":"BFnrd2780_CR166","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/BF00373882","volume":"430","author":"M Gschwentner","year":"1995","unstructured":"Gschwentner, M. et al. Antisense oligonucleotides suppress cell-volume-induced activation of chloride channels. Pflugers Arch. 430, 464\u2013470 (1995).","journal-title":"Pflugers Arch."},{"key":"BFnrd2780_CR167","doi-asserted-by":"crossref","first-page":"50163","DOI":"10.1074\/jbc.M300374200","volume":"278","author":"M Ritter","year":"2003","unstructured":"Ritter, M. et al. Cell swelling stimulates cytosol to membrane transposition of ICln. J. Biol. Chem. 278, 50163\u201350174 (2003).","journal-title":"J. Biol. Chem."},{"key":"BFnrd2780_CR168","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1042\/bj3310347u","volume":"331","author":"J Eggermont","year":"1998","unstructured":"Eggermont, J. et al. Is there a link between protein pICln and volume-regulated anion channels? Biochem. J. 331, 347\u2013349 (1998).","journal-title":"Biochem. J."},{"key":"BFnrd2780_CR169","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/0092-8674(94)90109-0","volume":"76","author":"GB Krapivinsky","year":"1994","unstructured":"Krapivinsky, G. B., Ackerman, M. J., Gordon, E. A., Krapivinsky, L. D. & Clapham, D. E. Molecular characterization of a swelling-induced chloride conductance regulatory protein, pICln. Cell 76, 439\u2013448 (1994).","journal-title":"Cell"},{"key":"BFnrd2780_CR170","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1074\/jbc.272.6.3615","volume":"272","author":"G Buyse","year":"1997","unstructured":"Buyse, G. et al. Expression of human pICln and ClC-6 in Xenopus oocytes induces an identical endogenous chloride conductance. J. Biol. Chem. 272, 3615\u20133621 (1997).","journal-title":"J. Biol. Chem."},{"key":"BFnrd2780_CR171","doi-asserted-by":"crossref","first-page":"4113","DOI":"10.1128\/MCB.19.6.4113","volume":"19","author":"WT Pu","year":"1999","unstructured":"Pu, W. T., Krapivinsky, G. B., Krapivinsky, L. & Clapham, D. E. pICln inhibits snRNP biogenesis by binding core spliceosomal proteins. Mol. Cell. Biol. 19, 4113\u20134120 (1999).","journal-title":"Mol. Cell. Biol."},{"key":"BFnrd2780_CR172","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/37151","volume":"390","author":"D Duan","year":"1997","unstructured":"Duan, D., Winter, C., Cowley, S., Hume, J. R. & Horowitz B. Molecular identification of a volume-regulated chloride channel. Nature 390, 417\u2013421 (1997).","journal-title":"Nature"},{"key":"BFnrd2780_CR173","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0896-6273(01)00189-1","volume":"29","author":"SM Stobrawa","year":"2001","unstructured":"Stobrawa, S. M. et al. Disruption of ClC-3, a chloride channel expressed on synaptic vesicles, leads to a loss of the hippocampus. Neuron 29, 185\u2013196 (2001).","journal-title":"Neuron"},{"key":"BFnrd2780_CR174","doi-asserted-by":"crossref","first-page":"17461","DOI":"10.1074\/jbc.M011667200","volume":"276","author":"KH Weylandt","year":"2001","unstructured":"Weylandt, K. H. et al. Human ClC-3 is not the swelling-activated chloride channel involved in cell volume regulation. J. Biol. Chem. 276, 17461\u201317467 (2001).","journal-title":"J. Biol. Chem."},{"key":"BFnrd2780_CR175","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1074\/jbc.M407030200","volume":"280","author":"M Hara-Chikuma","year":"2005","unstructured":"Hara-Chikuma, M. et al. ClC-3 chloride channels facilitate endosomal acidification and chloride accumulation. J. Biol. Chem. 280, 1241\u20131247 (2005).","journal-title":"J. Biol. Chem."},{"key":"BFnrd2780_CR176","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0079-6107(97)00021-7","volume":"68","author":"B Nilius","year":"1997","unstructured":"Nilius, B. et al. Properties of volume-regulated anion channels in mammalian cells. Prog. Biophys. Mol. Biol. 68, 69\u2013119 (1997).","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"BFnrd2780_CR177","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1038\/sj.bjp.0704413","volume":"134","author":"N Decher","year":"2001","unstructured":"Decher, N. et al. DCPIB is a novel selective blocker of I(Cl, swell) and prevents swelling-induced shortening of guinea-pig atrial action potential duration. Br. J. Pharmacol. 134, 1467\u20131479 (2001).","journal-title":"Br. J. Pharmacol."},{"key":"BFnrd2780_CR178","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00232-005-0836-6","volume":"209","author":"Y Okada","year":"2006","unstructured":"Okada, Y. et al. Volume-sensitive chloride channels involved in apoptotic volume decrease and cell death. J. Membr. Biol. 209, 21\u201329 (2006).","journal-title":"J. Membr. Biol."},{"key":"BFnrd2780_CR179","doi-asserted-by":"crossref","first-page":"9487","DOI":"10.1073\/pnas.140216197","volume":"97","author":"E Maeno","year":"2000","unstructured":"Maeno, E., Ishizaki, Y., Kanaseki, T., Hazama, A. & Okada, Y. Normotonic cell shrinkage because of disordered volume regulation is an early prerequisite to apoptosis. Proc. Natl Acad. Sci. USA 97, 9487\u20139492 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrd2780_CR180","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1002\/dvdy.21676","volume":"237","author":"JR Rock","year":"2008","unstructured":"Rock, J. R. & Harfe, B. D. Expression of TMEM16 paralogs during murine embryogenesis. Dev. Dyn. 237, 2566\u20132574 (2008).","journal-title":"Dev. Dyn."},{"key":"BFnrd2780_CR181","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1089\/10430349950018274","volume":"10","author":"MK Mansoura","year":"1999","unstructured":"Mansoura, M. K., Biwersi, J., Ashlock, M. A. & Verkman, A. S. Fluorescent chloride indicators to assess the efficacy of CFTR cDNA delivery. Hum. Gene Ther. 10, 861\u2013875 (1999).","journal-title":"Hum. Gene Ther."},{"key":"BFnrd2780_CR182","unstructured":"Verkman, A. S. in Physiology and Pathology of Chloride Transporters and Channels in the Nervous System: From Molecules to Disease (eds Alvarez-Leefmans, F. J. & Delpire, E.) (Elsevier, in the press)."},{"key":"BFnrd2780_CR183","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.drudis.2007.11.009","volume":"13","author":"E Molokanova","year":"2008","unstructured":"Molokanova, E. & Savchenko, A. Bright future of optical assays for ion channel drug discovery. Drug Discov. Today 13, 14\u201322 (2008).","journal-title":"Drug Discov. Today"},{"key":"BFnrd2780_CR184","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s11068-008-9026-7","volume":"36","author":"BJ Baker","year":"2008","unstructured":"Baker, B. J. et al. Genetically encoded fluorescent sensors of membrane potential. Brain Cell. Biol. 36, 53\u201367 (2008).","journal-title":"Brain Cell. Biol."}],"container-title":["Nature Reviews Drug Discovery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrd2780.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrd2780","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrd2780.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T02:05:36Z","timestamp":1738893936000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrd2780"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1,19]]},"references-count":184,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["BFnrd2780"],"URL":"https:\/\/doi.org\/10.1038\/nrd2780","relation":{},"ISSN":["1474-1776","1474-1784"],"issn-type":[{"value":"1474-1776","type":"print"},{"value":"1474-1784","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1,19]]}}}